Skip survey header

Novo Nordisk THSNA 2022 Post-Meeting Survey

Are HIGHER FACTOR LEVELS a rising consideration when selecting a hemophilia treatment?

A Novo Nordisk-Sponsored Product Theater
To help us improve future events, please complete this brief survey.

Based on the rating scales provided, please circle your response to each of the following statements. Please also provide comments, if you should have them, in the open space at the end.
1. Please rate the overall presentation.
Poor
(1)
(2)
Average
(3)		(4)
Excellent
(5)
2. Please rate the importance of high factor levels when selecting a product.
Not relevant
(1)
(2)
Relevant
(3)		(4)
Highly relevant
(5)
3. Please rate your agreement with the following statement: The presentation and discussion caused me to reevaluate my approach to treating patients with bleeding disorders. 
Strongly disagree
(1)
(2)
Neutral
(3)		(4)
Strongly agree
(5)
This program is sponsored by Novo Nordisk.
This is a promotional education presentation; it will not be certified for continuing medical education credit.
Thank you for your participation and feedback!

Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, New Jersey 08536 U.S.A.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.

© 2022 Novo Nordisk                  Printed in the U.S.A.               US22HRBD00115         July 2022      

  

  

0%